Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1996 1
1999 1
2002 1
2003 2
2005 3
2006 1
2007 6
2008 9
2009 7
2010 5
2011 8
2012 7
2013 6
2014 5
2015 5
2016 5
2017 4
2018 8
2019 5
2020 3
2021 3
2022 3
2023 6
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Results by year

Filters applied: . Clear all
Page 1
Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial.
Di Rocco M, Forleo-Neto E, Pignolo RJ, Keen R, Orcel P, Funck-Brentano T, Roux C, Kolta S, Madeo A, Bubbear JS, Tabarkiewicz J, Szczepanek M, Bachiller-Corral J, Cheung AM, Dahir KM, Botman E, Raijmakers PG, Al Mukaddam M, Tile L, Portal-Celhay C, Sarkar N, Hou P, Musser BJ, Boyapati A, Mohammadi K, Mellis SJ, Rankin AJ, Economides AN, Trotter DG, Herman GA, O'Meara SJ, DelGizzi R, Weinreich DM, Yancopoulos GD, Eekhoff EMW, Kaplan FS. Di Rocco M, et al. Among authors: madeo a. Nat Med. 2023 Oct;29(10):2615-2624. doi: 10.1038/s41591-023-02561-8. Epub 2023 Sep 28. Nat Med. 2023. PMID: 37770652 Free PMC article. Clinical Trial.
Patent Foramen Ovale and Cryptogenic Stroke: Integrated Management.
Lucà F, Pino PG, Parrini I, Di Fusco SA, Ceravolo R, Madeo A, Leone A, La Mair M, Benedetto FA, Riccio C, Oliva F, Colivicchi F, Gulizia MM, Gelsomino S. Lucà F, et al. Among authors: madeo a. J Clin Med. 2023 Mar 1;12(5):1952. doi: 10.3390/jcm12051952. J Clin Med. 2023. PMID: 36902748 Free PMC article. Review.
Remote monitoring: Doomed to let down or an attractive promise?
Lucà F, Cipolletta L, Di Fusco SA, Iorio A, Pozzi A, Rao CM, Ingianni N, Benvenuto M, Madeo A, Fiscella D, Benedetto D, Francese GM, Gelsomino S, Zecchin M, Gabrielli D, Gulizia MM. Lucà F, et al. Among authors: madeo a. Int J Cardiol Heart Vasc. 2019 May 30;24:100380. doi: 10.1016/j.ijcha.2019.100380. eCollection 2019 Sep. Int J Cardiol Heart Vasc. 2019. PMID: 31193998 Free PMC article. Review.
Janus kinase 2 inhibitors in myeloproliferative disorders.
Lucia E, Recchia AG, Gentile M, Bossio S, Vigna E, Mazzone C, Madeo A, Morabito L, Gigliotti V, De Stefano L, Caruso N, Servillo P, Franzese S, Bisconte MG, Gentile C, Morabito F. Lucia E, et al. Among authors: madeo a. Expert Opin Investig Drugs. 2011 Jan;20(1):41-59. doi: 10.1517/13543784.2011.538382. Epub 2010 Dec 4. Expert Opin Investig Drugs. 2011. PMID: 21128825 Review.
Epigenetic regulation in myelodysplastic syndromes: implications for therapy.
Vigna E, Recchia AG, Madeo A, Gentile M, Bossio S, Mazzone C, Lucia E, Morabito L, Gigliotti V, Stefano LD, Caruso N, Servillo P, Franzese S, Fimognari F, Bisconte MG, Gentile C, Morabito F. Vigna E, et al. Among authors: madeo a. Expert Opin Investig Drugs. 2011 Apr;20(4):465-93. doi: 10.1517/13543784.2011.559164. Epub 2011 Mar 8. Expert Opin Investig Drugs. 2011. PMID: 21381982 Review.
Lenalidomide in the treatment of chronic lymphocytic leukemia.
Gentile M, Recchia AG, Vigna E, Mazzone C, Lucia E, Gigliotti V, Bossio S, Madeo A, Morabito L, Servillo P, Franzese S, Caruso N, De Stefano L, Bisconte MG, Gentile C, Morabito F. Gentile M, et al. Among authors: madeo a. Expert Opin Investig Drugs. 2011 Feb;20(2):273-86. doi: 10.1517/13543784.2011.546343. Epub 2011 Jan 10. Expert Opin Investig Drugs. 2011. PMID: 21214505 Review.
91 results